Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD
JB Wetmore, S Liu, R Krebill, R Menard… - Clinical Journal of the …, 2010 - journals.lww.com
Background and objectives: Fibroblast growth factor-23 (FGF23) levels are elevated in
ESRD and have been associated with adverse outcomes. The effects of various treatments
for secondary hyperparathyroidism on FGF23 levels in ESRD have not been examined in a
clinical trial.
ESRD and have been associated with adverse outcomes. The effects of various treatments
for secondary hyperparathyroidism on FGF23 levels in ESRD have not been examined in a
clinical trial.